Residual Gastric Volume After the Ingestion of Supplements Containing Carbohydrates and Whey Protein
1 other identifier
interventional
6
1 country
1
Brief Summary
Oral supplements (OS) containing carbohydrates are being used 2h before anesthesia. The addition of a nitrogen source would improve these drinks designed for the abbreviation of preoperative fasting. The gastric emptying of an oral supplement containing whey protein in addition to carbohydrates was investigated. This is a randomized crossover study including six healthy young volunteers who were submitted to abdominal MRI in 3 phases: 1) after a overnight fast, 2) after drank 200 mL of an OS containing whey protein and carbohydrates (no lipids), and 3) 3h after ingestion of the mentioned OS. The gastric residual volume (GRV) will be evaluate by MRI. The overall findings would allow us to conclude whether the GRV, assessed by MRI, in healthy young volunteers after three hours of the ingestion of 200 ml of an oral supplement containing carbohydrates associated with whey proteins is similar to the GRV found after an overnight fast. This pilot study will add important information to allow future randomized trials including an arm with patients undergoing elective surgical procedures with a 3h fasting after the ingestion of an OS containing whey protein and carbohydrates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedFirst Submitted
Initial submission to the registry
June 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 10, 2022
CompletedOctober 10, 2022
October 1, 2022
2 months
June 26, 2022
October 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastric Residual Volume
Gastric residual Volume in cmˆ3 assessed by MRI 3h after ingestion of the OS
3 hours
Study Arms (3)
Overnight Fast
SHAM COMPARATORAfter an overnight fast period of eight hours, the 6 participants will attend the Radiology Service of the Hospital de Câncer, Cuiaba, Brazil to perform MRI images of the upper abdomen with the objective of measuring the fasting GRV. GRV will be evaluated by tracking the region of interest (ROI) in each slice, forming a volume by the sum of all ROIs (phase 1).
Oral Supplement
ACTIVE COMPARATOREach of the 6 participants while still inside the MRI exam room just after the MRI in fast condition, will ingest 200mL of the study oral supplement (OS). The individual will be immediately positioned in the supine position and another MRI scan will be carried out. In this second phase, GRV will be evaluated again as in phase 1 (phase 2).
3h after ingestion
ACTIVE COMPARATORFinally, phase 3 will be performed after a 3-hour pause. All volunteers, while still in the Radiology Service and fasted after the ingestion of the OS described in phase 2, will be submitted to a third MRI scan of the upper abdomen to measure again the GRV as previously described.
Interventions
Ingestion of an oral supplement containing carbohydrates and whey protein
Residual Gastric Volume assessed by MRI after overnight fast (8h)
Eligibility Criteria
You may qualify if:
- Male
- Young
- Healthy volunteers
You may not qualify if:
- Gastroparesis
- Any gastrointestinal condition,
- Any chronic disease,
- Alcohol or any drug ingestion the day before of the MRI study
- Not completion of the 3 phases of the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Federal University of Mato Grossolead
- Univag Centro Universitáriocollaborator
Study Sites (1)
Centro Universitário de Varzea Grande (UNIVAG)
Várzea Grande, Mato Grosso, 78.118-000, Brazil
Related Publications (4)
de Aguilar-Nascimento JE, Caporossi C, Metelo JS, Tanajura GH, Canevari-de-Oliveira M, da Cunha Costa R. Safe intake of an oral supplement containing carbohydrates and whey protein shortly before sedation to gastroscopy; a double blind, randomized trial. Nutr Hosp. 2014 Mar 1;29(3):681-6. doi: 10.3305/nh.2014.29.3.7161.
PMID: 24559015BACKGROUNDPerrone F, da-Silva-Filho AC, Adorno IF, Anabuki NT, Leal FS, Colombo T, da Silva BD, Dock-Nascimento DB, Damiao A, de Aguilar-Nascimento JE. Effects of preoperative feeding with a whey protein plus carbohydrate drink on the acute phase response and insulin resistance. A randomized trial. Nutr J. 2011 Jun 13;10:66. doi: 10.1186/1475-2891-10-66.
PMID: 21668975BACKGROUNDPimenta GP, de Aguilar-Nascimento JE. Prolonged preoperative fasting in elective surgical patients: why should we reduce it? Nutr Clin Pract. 2014 Feb;29(1):22-8. doi: 10.1177/0884533613514277. Epub 2013 Dec 11.
PMID: 24336400BACKGROUNDNogueira PLB, da Silva MR, Dock-Nascimento DB, de Aguilar-Nascimento JE. Residual gastric volume after 3 h of the ingestion of an oral supplement containing carbohydrates alone or associated with whey protein: a randomized crossover pilot study. Perioper Med (Lond). 2022 Dec 27;11(1):56. doi: 10.1186/s13741-022-00289-6.
PMID: 36575506DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose E Aguilar-Nascimento, MD, PhD
Univag Centro Universitário
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigator will not participate of the 3 MRI sessions. Outcome Assessor will receive the data for statistical analysis blinded
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 26, 2022
First Posted
October 10, 2022
Study Start
April 1, 2022
Primary Completion
May 30, 2022
Study Completion
May 30, 2022
Last Updated
October 10, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- As soon as study is registered
- Access Criteria
Share will be possible by request via email